Written question asked by Liam Fox (Conservative) on Tuesday, 26 February 2002, in the House of Commons. It was due for an answer on Thursday, 2 May 2002. It was answered by Yvette Cooper (Labour) on Thursday, 2 May 2002 on behalf of the Department of Health.
Dept of Health
- Question
- To ask the Secretary of State for Health, what the commercial basis of the decision to award the anti-TB vaccination contract to Powderject was. - (Holding answer 28 February 2002).
- Answer
-
Dr. Fox: To ask the Secretary of State for Health what the commercial basis of the decision to award the anti-TB vaccination contract to Powderject was. [38678] Yvette Cooper: [holding answer 28 February 2002]: The contract was awarded to Powderject under European Union public procurement regulations. Powderject was the only manufacturer with a United Kingdom licence to supply BCG vaccine at that time.
Secondary information
- Type
- Written question
- Reference
- 38678; 384 c1007W;384 c1008W
- Session
- 2001-02
- Subjects
- Contracts Vaccination Tuberculosis PowderJect
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2016-10-07 16:11:12 +0100
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_752406
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_752406
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_752406